Vestal Point Capital’s Medtronic MDT Stock Holding History

Vestal Point Capital’s Portfolio MDT Stock Details MDT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q3	–	Sell	-195,000	Closed	-$17M	–	88
2025 Q2	$17M	Buy	+195,000	New	+$16.5M	0.89%	38

Other funds holding MDT

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Vestal Point Capital's MDT Position: Q3 2025 in Review

Vestal Point Capital sold out of Medtronic (MDT) in Q3 2025, closing a stake of 195,000 shares — an estimated $17M sold.

Vestal Point Capital first reported a position in MDT in Q2 2025 and held it in 1 quarter. The position peaked at $17M in Q2 2025. 2,169 funds tracked by Wall St. Rank hold MDT as of Q3 2025.

Vestal Point Capital reported no remaining Medtronic position as of Q3 2025 after selling out during the quarter.
Vestal Point Capital sold 195,000 Medtronic shares in Q3 2025, an estimated $17M.
Vestal Point Capital first reported a position in Medtronic in Q2 2025 and held it in 1 quarter.
Vestal Point Capital's Medtronic position peaked at $17M in Q2 2025.
2,169 funds tracked by Wall St. Rank held Medtronic as of Q3 2025.

Based on Vestal Point Capital's 13F filing for Q3 2025, filed 14 Nov 2025.